ZA978625B - Oral preparation, comprising at least one pharmaceutical active compound in a matrix which is swellable in aqueous medium. - Google Patents

Oral preparation, comprising at least one pharmaceutical active compound in a matrix which is swellable in aqueous medium.

Info

Publication number
ZA978625B
ZA978625B ZA9708625A ZA978625A ZA978625B ZA 978625 B ZA978625 B ZA 978625B ZA 9708625 A ZA9708625 A ZA 9708625A ZA 978625 A ZA978625 A ZA 978625A ZA 978625 B ZA978625 B ZA 978625B
Authority
ZA
South Africa
Prior art keywords
swellable
aqueous medium
matrix
active compound
pharmaceutical active
Prior art date
Application number
ZA9708625A
Other languages
English (en)
Inventor
Karsten Cremer
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of ZA978625B publication Critical patent/ZA978625B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9708625A 1996-09-28 1997-09-26 Oral preparation, comprising at least one pharmaceutical active compound in a matrix which is swellable in aqueous medium. ZA978625B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19640062A DE19640062B4 (de) 1996-09-28 1996-09-28 Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff

Publications (1)

Publication Number Publication Date
ZA978625B true ZA978625B (en) 1998-03-26

Family

ID=7807265

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9708625A ZA978625B (en) 1996-09-28 1997-09-26 Oral preparation, comprising at least one pharmaceutical active compound in a matrix which is swellable in aqueous medium.

Country Status (23)

Country Link
US (1) US6238698B1 (xx)
EP (1) EP0946150B1 (xx)
JP (1) JP2001504807A (xx)
KR (1) KR100493139B1 (xx)
CN (1) CN1139378C (xx)
AT (1) ATE213933T1 (xx)
AU (1) AU724802B2 (xx)
CA (1) CA2260845C (xx)
CZ (1) CZ291258B6 (xx)
DE (2) DE19640062B4 (xx)
DK (1) DK0946150T3 (xx)
ES (1) ES2174296T3 (xx)
HU (1) HU227865B1 (xx)
IL (1) IL129171A (xx)
MY (1) MY130959A (xx)
NO (1) NO991477L (xx)
NZ (1) NZ333401A (xx)
PL (1) PL188392B1 (xx)
PT (1) PT946150E (xx)
SI (1) SI0946150T1 (xx)
SK (1) SK282709B6 (xx)
WO (1) WO1998013028A1 (xx)
ZA (1) ZA978625B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
BRPI0615860B8 (pt) 2005-09-09 2021-05-25 Labopharm Barbados Ltd composição farmacêutica de liberação prolongada monolítica sólida
US20080286343A1 (en) * 2007-05-16 2008-11-20 Dzenana Cengic Solid form
US8226967B2 (en) 2008-11-27 2012-07-24 Basf Se Surface active proteins as excipients in solid pharmaceutical formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1237904B (it) 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
US5603956A (en) * 1990-11-27 1997-02-18 Labopharm Inc. Cross-linked enzymatically controlled drug release
WO1994002121A1 (en) * 1992-07-24 1994-02-03 Labopharm Inc. Cross-linked polyhydroxylic material for enzymatically controlled drug release
US5616343A (en) * 1993-03-25 1997-04-01 Labopharm, Inc. Cross-linked amylose as a binder/disintegrant in tablets
DE4341442C2 (de) 1993-12-04 1998-11-05 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoffen sowie ihre Verwendung
DE4416926C2 (de) 1994-05-13 2000-01-13 Lohmann Therapie Syst Lts Verfahren zur Herstellung von Vorrichtungen zur kontrollierten Freisetzung von Wirkstoffen
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
WO2007095324A1 (en) 2006-02-14 2007-08-23 The Procter & Gamble Company Personal care compositions comprising responsive particles

Also Published As

Publication number Publication date
JP2001504807A (ja) 2001-04-10
WO1998013028A1 (de) 1998-04-02
SI0946150T1 (en) 2002-08-31
HUP9903115A2 (hu) 2000-02-28
EP0946150B1 (de) 2002-03-06
HUP9903115A3 (en) 2000-03-28
DE19640062B4 (de) 2006-04-27
NO991477D0 (no) 1999-03-26
SK38799A3 (en) 2000-03-13
IL129171A (en) 2001-11-25
DK0946150T3 (da) 2002-06-24
CA2260845A1 (en) 1998-04-02
PL332577A1 (en) 1999-09-27
AU724802B2 (en) 2000-09-28
US6238698B1 (en) 2001-05-29
HU227865B1 (en) 2012-05-29
CN1231600A (zh) 1999-10-13
SK282709B6 (sk) 2002-11-06
ATE213933T1 (de) 2002-03-15
NO991477L (no) 1999-03-26
PT946150E (pt) 2002-08-30
CA2260845C (en) 2005-11-22
CZ101399A3 (cs) 1999-07-14
CN1139378C (zh) 2004-02-25
PL188392B1 (pl) 2005-01-31
CZ291258B6 (cs) 2003-01-15
NZ333401A (en) 1999-10-28
IL129171A0 (en) 2000-02-17
DE19640062A1 (de) 1998-04-09
EP0946150A1 (de) 1999-10-06
AU4619397A (en) 1998-04-17
KR100493139B1 (ko) 2005-06-02
ES2174296T3 (es) 2002-11-01
DE59706576D1 (de) 2002-04-11
KR20010029533A (ko) 2001-04-06
MY130959A (en) 2007-07-31

Similar Documents

Publication Publication Date Title
GR3003031T3 (en) Granule remaining in stomach
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
ITMI922617A1 (it) Forme matriciali multistrato per il rilascio controllato di principi attivi
FI944035A (fi) Tramadolisuolaa sisältävä lääkeaine, jolla on viivästynyt vaikuttavan aineen vapautuminen
AU1023788A (en) Therapeutic system for sparingly soluble active ingredients
AU4989997A (en) Soluble form osmotic dose delivery system
ZA977832B (en) Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents.
MX9706785A (es) Formas de dosificacion farmaceutica oral que comprenden un inhibidor de la bomba de protones y un agente antiacido o alginato.
BR9708772A (pt) "comprimidos famacêuticos de liberação controlada que contém um veìculo à base de amilose reticulada e hidróxi propil metil celulose"
AU4464897A (en) Method for preparing a pharmaceutical composition with modified release of the active principle, comprising a matrix
ZA978625B (en) Oral preparation, comprising at least one pharmaceutical active compound in a matrix which is swellable in aqueous medium.
MY111126A (en) Transdermal therapeutic system comprising the active substance acetylsalicylic acid.
CA2283408A1 (en) Swallow tablet comprising paracetamol
AU657314B2 (en) Transdermal therapeutic plaster
EP0968712A4 (en) Patch containing Felbinac
EP0070127A3 (en) Tablets
EP0903226A3 (en) Heat sensitive planographic printing plate, its manufacturing method and image forming method employing the same
CA2204157A1 (en) Children-proof package for active substance-containing plaster
EP1020182A3 (en) A two-layer pharmaceutical tablet comprising an nsaid and misoprostol
ES8603262A1 (es) Perfeccionamientos en formas farmaceuticas solidas para uso oral
EP0974361A4 (en) METHOD OF USING AN ANTI-ACID AGENT AND PHARMACEUTICAL PREPARATION CONTAINING THE SAME
HUP9902681A2 (hu) Térhálósított amilózt és hidroxi-propil-metil-cellulózt tartalmazó hordozóval készült szabályozott felszabadulású tabletta gyógyszerkészítmény
AU4015097A (en) Transdermal therapeutic system having an active compound combination comprising oestriol
IT1275267B (it) Forme farmaceutiche a rilascio modificato di canrenoato di potassio costituite da matrici idrofile rivestite
CA2198092A1 (en) Transdermal therapeutic system with protection against hydrolysis